Pierre Fabre Iberica, S.A.

Poland

All drugs from this manufacturer

  • CLARELUX

    It is used in short-term therapy for scalp skin diseases, such as psoriasis, that do not respond to the use of weaker corticosteroids.

    Dosage form: cream for skin

    Active substance Dosage
    clobetasol propionate 500 micrograms/g

    ATC: D07AD01

  • It is used for the short-term treatment of steroid-responsive scalp skin diseases, such as scalp psoriasis, which do not improve with weaker medications.

    Dosage form: cream for skin

    Active substance Dosage
    clobetasol propionate 500 micrograms/g

    ATC: D07AD01

  • The medicine is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC: D10BA01

  • It is used in the treatment of severe forms of acne (e.g., nodular, conglobate acne, or acne with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC: D10BA01

  • The medicinal product is intended for the treatment of severe forms of acne (nodular, conglobate, or with a risk of permanent scarring) that do not respond to standard antibiotic treatment or topical medications.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    isotretinoin 5 mg

    ATC: D10BA01

  • The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient). It is intended for adults and children over 10 years of age.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07

  • It is used for the treatment of anemia resulting from iron deficiency and for the prevention of iron deficiency in pregnant women (when dietary iron intake is insufficient).

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07

  • The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women whose diet is insufficient. It is intended for adults and children over 10 years of age.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07

  • The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient).

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07

  • The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient). It is intended for adults and children over 10 years of age.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07